The New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NERCE) is a network of research collaborations that, since 2003, has supported basic science and translational research for the development of preventive and therapeutic interventions against Priority Pathogens listed by NIAID as emerging and re-emerging infectious disease threats. The Center has been a focal point for New England's research and development in Priority Pathogens, and has been applying recent dramatic advances in genomics, proteomics, structural biology, immunology, vaccinology, chemistry, drug screening, and material sciences to problems of importance in combating these threats. The NERCE effort is directed towards catalyzing collaborative work, creative thinking, and innovative solutions to the myriad challenges posed by infectious diseases. NERCE is one of eleven Regional Centers of Excellence located across the country.
Lupoli, T.J., Lebar, M.D., Markovski, M., Bernhardt, T., Kahne, D., and Walker, S. (2014). Lipoprotein Activators Stimulate Escherichia coli Penicillin-Binding Proteins by Different Mechanisms. J Am Chem Soc 136, 52-55. PMID: 24341982.
Morin, B., and Whelan, S.P. (2014). Sensitivity of the polymerase of vesicular stomatitis virus to 2' substitutions in the template and nucleotide triphosphate during initiation and elongation. J Biol Chem. PMID: 24526687.
Hassan, M.A., Butty, V.L., Jensen, K.D., and Saeij, J.P. (2013). The genetic basis for individual differences in mRNA splicing and APOBEC1 editing activity in murine macrophages. Genome research. PMID: 24249727.
Piccinotti, S., Kirchhausen, T., and Whelan, S.P. (2013). Uptake of rabies virus into epithelial cells by clathrin-mediated endocytosis depends upon actin. J Virol 87, 11637-11647. PMID: 23966407. PMCID: 3807345.